Brief: Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering Of Common Stock Priced At-The-Market
12/02/2021 12:22
Feb 12 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS ANNOUNCES $7.7 MILLION REGISTERED
DIRECT
OFFERING OF COMMON STOCK PRICED AT-THE-MARKET
* PHIO PHARMACEUTICALS CORP - PURCHASE AND SALE OF 2.2
MILLION
SHARES AT $3.42 PER SHARE
Source text for Eikon: ID:nPn927cwva
Further company coverage: PHIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing